Search
Cemdisiran
go.drugbank.com/drugs/DB16121InvestigationalCemdisiran is under investigation in clinical trial NCT03841448 (A Study of Cemdisiran in Adults With Immunoglobulin a Nephropathy (Igan)).
TAK-653
go.drugbank.com/drugs/DB16304InvestigationalTAK-653 is under investigation in clinical trial NCT03312894 (Efficacy and Safety of TAK-653 in Treatment-resistant Depression).
Posdinemab
go.drugbank.com/drugs/DB18941InvestigationalPosdinemab is under investigation in clinical trial NCT04619420 (A Study of JNJ-63733657 in Participants With Early Alzheimer's Disease).
TAK-071
go.drugbank.com/drugs/DB18954InvestigationalTAK-071 is under investigation in clinical trial NCT04334317 (A Study of TAK-071 in People With Parkinson Disease).
Rezpegaldesleukin
go.drugbank.com/drugs/DB18992InvestigationalRezpegaldesleukin is under investigation in clinical trial NCT04433585 (A Study of LY3471851 in Adults With Systemic Lupus Erythematosus (SLE)).
Bovhyaluronidase azoximer
go.drugbank.com/drugs/DB19020InvestigationalBovhyaluronidase azoximer is under investigation in clinical trial NCT06458543 (Optimization of Bacterial Vaginosis Treatment in Women of Reproductive Age).
Minigastrin
go.drugbank.com/drugs/DB19196InvestigationalMinigastrin is under investigation in clinical trial NCT06155994 (68ga-dota-mgs5 PET/CT in Patients With Advanced Neuroendocrine Tumours).
Exidavnemab
go.drugbank.com/drugs/DB19452InvestigationalExidavnemab is under investigation in clinical trial NCT06671938 (Safety, Tolerability, and Pharmacokinetics of Exidavnemab in Patients With Parkinson's Disease).
Sulfaquinoxaline
go.drugbank.com/drugs/DB11464ExperimentalVet approvedSulfaquinoxaline is a veterinary medicine which can be given to cattle and sheep to treat coccidiosis.It is available in Pakistan with Sanna Laboratories in combination with Amprolium and Vitamin K as
Products: SN ANTI-COCCI 45 mg/ml ORAL SOLUTIONARI-0001
go.drugbank.com/drugs/DB30635InvestigationalARI-0001 is a biologic drug. ARI-0001 is under investigation in clinical trial NCT05641428 (Comparison of Point-of-care Produced CAR T-cell with Commercial CAR T-cells in Patients with R/R LBCL).